Background illustration for clinical trials search

Regeneron Pharmaceuticals Clinical Trials

Find clinical trials for Regeneron Pharmaceuticals. Search for Regeneron Pharmaceuticals clinical trials in different cities and states across the United States.

Filter

Safety in Adult Participants With Atrial Fibrillation Who Are Treated With Anticoagulation

for
Atrial Fibrillation (AF)
Location: Moncton, Rimouski, Boston MA, Quebec, Sherbrooke,
Sponsor: Regeneron Pharmaceuticals

Sex: All

Age: 18+

Code: NCT07175428

Phase 2, Recruiting

A Safety and Efficacy Long-Term Follow-up Study of Adult Participants Treated With Gene Modified T Cells

for
Long Term Safety Following GM T Cell Therapy
Location: Nashville TN
Sponsor: Regeneron Pharmaceuticals

Sex: All

Age: 18+

Code: NCT06798298

Recruiting

Safety and Drug Concentrations of REGN20934 in Adults With Overweight or Obesity

for
Overweight or Obesity
Location: Glendale CA
Sponsor: Regeneron Pharmaceuticals

Sex: All

Age: 18 - 65

Code: NCT07594093

Phase 1, Recruiting

A Phase 1 Study of BPX-601 CAR T-Cell Therapy in Adult Participants With Prostate Cancer That Has Returned, is Resistant to Treatment and Has Spread

for
Prostate Cancer
Location: Hackensack NJ, Atlanta GA, Portland OR
Sponsor: Regeneron Pharmaceuticals

Sex: Male

Age: 18+

Code: NCT07543055

Phase 1, Recruiting

A Phase 2a Study of ALN-PNP With and Without a GLP1R Agonist in Adult Patients With Homozygous PNPLA3-Related MASLD

for
Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD),
Location: Jupiter FL, Miami FL, Metairie LA, Georgetown TX,
Sponsor: Regeneron Pharmaceuticals

Sex: All

Age: 18 - 70+

Code: NCT07527910

Phase 2, Recruiting

Interested in new trials?

Get alerts for new trials in your area by subscribing now

Subscriber Image

A Study to Compare Linvoseltamab and Daratumumab Treatment in High-Risk Smoldering Multiple Myeloma (HR-SMM)

for
High Risk Smoldering Multiple Myeloma (HR-SMM)
Location: Boston MA, New York NY, Columbus OH, Detroit MI,
Sponsor: Regeneron Pharmaceuticals

Sex: All

Age: 18+

Code: NCT07393282

Phase 3, Recruiting

Reducing Adverse Vascular Outcomes With Factor XI Inhibition in Adult Participants With Peripheral Artery Disease

for
Peripheral Artery Disease (PAD)
Location: Mooresville NC, Tampa FL, Crystal River FL,
Sponsor: Regeneron Pharmaceuticals

Sex: All

Age: 18+

Code: NCT07318610

Phase 3, Recruiting

Study of REGN13335 in Adult Participants With Pulmonary Arterial Hypertension (PAH)

for
Pulmonary Arterial Hypertension (PAH)
Location: Boston MA, Cincinnati OH, Omaha NE, Aurora CO
Sponsor: Regeneron Pharmaceuticals

Sex: All

Age: 18+

Code: NCT07318597

Phase 2, Recruiting

A Study to Evaluate ALN-CIDEB in Adult Participants With Metabolic Dysfunction-Associated Steatotic Liver Disease or With Metabolic Dysfunction-Associated Steatohepatitis (MASLD/MASH)

for
Metabolic Dysfunction-Associated Steatotic Liver Disease,
Location: Tucson AZ, Chandler AZ
Sponsor: Regeneron Pharmaceuticals

Sex: All

Age: 18 - 65

Code: NCT06836609

Phase 1, Phase 2, Recruiting

A Study of Dupilumab in Small Children With an Allergic Condition of the Esophagus (Food Pipe): Eosinophilic Esophagitis

for
Eosinophilic Esophagitis (EoE)
Location: Boston MA, New York NY, Philadelphia PA,
Sponsor: Regeneron Pharmaceuticals

Sex: All

Age: 0 - 6

Code: NCT07112378

Phase 3, Recruiting

A Study to Compare Linvoseltamab Monotherapy and Linvoseltamab + Carfilzomib Combination Therapy With Standard-of-Care Combination Regimens in Adult Participants With Relapsed/Refractory Multiple Myeloma (RRMM)

for
Relapsed and/or Refractory Multiple Myeloma (RRMM)
Location: New York NY, Columbus OH, Atlanta GA, Houston TX,
Sponsor: Regeneron Pharmaceuticals

Sex: All

Age: 18+

Code: NCT07222761

Phase 3, Recruiting

REGN7508 Versus Apixaban and Enoxaparin for Thromboprophylaxis After Total Knee Arthroplasty in Adults

for
Venous Thromboembolism (VTE)
Location: Boston MA, Westwood NJ, Baltimore MD, Durham NC,
Sponsor: Regeneron Pharmaceuticals

Sex: All

Age: 18+

Code: NCT07015905

Phase 3, Recruiting

Investigation of Ubamatamab Combination Therapy in Adult Participants With Platinum-Resistant Ovarian Cancer

for
Ovarian Cancer, Fallopian Tube Cancer,
Location: Boston MA, Quebec, Greenfield Park, Montreal, Miami FL,
Sponsor: Regeneron Pharmaceuticals

Sex: Female

Age: 18+

Code: NCT06787612

Phase 2, Recruiting

Dose Escalation Study With Bispecific Antibodies in Adult Participants With Lupus Nephritis

for
Lupus Nephritis (LN)
Location: Rochester MN, Houston TX, San Francisco CA
Sponsor: Regeneron Pharmaceuticals

Sex: All

Age: 18 - 60

Code: NCT06975787

Phase 1, Recruiting

REGN7508 in Adult Participants for Prevention of Cancer-Associated Thrombosis

for
Cancer-Associated Thrombosis (CAT)
Location: New York NY, North Miami Beach FL, Hialeah FL,
Sponsor: Regeneron Pharmaceuticals

Sex: All

Age: 18+

Code: NCT07410117

Phase 3, Recruiting

A Window of Opportunity Trial to Learn if Linvoseltamab is Safe and Well Tolerated, and How Well it Works in Adult Participants With Recently Diagnosed Multiple Myeloma Who Have Not Already Received Treatment

for
Multiple Myeloma
Location: Stony Brook NY, Mineola NY, New York NY,
Sponsor: Regeneron Pharmaceuticals

Sex: All

Age: 18+

Code: NCT05828511

Phase 1, Phase 2, Recruiting

A Study to Examine the Effects of Novel Therapy Linvoseltamab in Combination With Other Cancer Treatments for Adult Participants With Multiple Myeloma That is Resistant to Current Standard of Care Treatments

for
Multiple Myeloma
Location: Boston MA, New York NY, Chapel Hill NC,
Sponsor: Regeneron Pharmaceuticals

Sex: All

Age: 18+

Code: NCT05137054

Phase 1, Recruiting

A Precision Medicine Approach Using Gene Silencing to Treat a Chronic Liver Disease Called Metabolic Dysfunction-Associated Steatohepatitis (MASH) in Adult Participants at Increased Genetic Risk for This Condition

for
Metabolic Dysfunction-Associated SteatoHepatitis (MASH)
Location: New York NY, Philadelphia PA, Hershey PA, Danville PA,
Sponsor: Regeneron Pharmaceuticals

Sex: All

Age: 18 - 70+

Code: NCT05519475

Phase 2, Recruiting

An Observational Extension Study for Adult Patients Treated in Study R5459-RT-1944 Who Receive a Kidney Transplant

for
Chronic Kidney Disease (CKD)
Location: New York NY, Philadelphia PA, Baltimore MD, Chicago IL,
Sponsor: Regeneron Pharmaceuticals

Sex: All

Age: 18 - 70

Code: NCT05106387

Recruiting

A Trial to Find Out if REGN5678 (Nezastomig) is Safe and How Well it Works Alone or in Combination With Cemiplimab for Adult Participants With Metastatic Castration-Resistant Prostate Cancer and Other Tumors

for
Metastatic Castration-Resistant Prostate Cancer (mCRPC),
Location: Boston MA, Providence RI, New Haven CT, New York NY,
Sponsor: Regeneron Pharmaceuticals

Sex: All

Age: 18+

Code: NCT03972657

Phase 1, Phase 2, Recruiting